No person knows for sure what the future will hold for stocks in the new year. However, it can be fun to attempt to predict what might happen.

Three Fool.com contributors have done just that. Here's why they think that Axsome Therapeutics (NASDAQ: AXSM), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) will soar in 2024.

Prosper Junior Bakiny (Axsome Therapeutics): The past two years have been transformative for Axsome Therapeutics. The company finally became a commercial-stage biotech by marketing two therapies, from which it is generating some sales. That was an important milestone, but Axsome's revenue remains modest while it is still chronically unprofitable.

Continue reading

Source Fool.com